Dopaminergic Influence on Thyrotropin Secretion in Primary Hypothyroidism

Abstract

This study was conducted to assess the influence of dopamine on thyrotropin secretion in patients with primary hypothyroidism before and after optimized L-thyroxin replacement therapy. Thyrotropin responses to dopamine infusion (4 µg/kg/min over 3 hours) and IV metoclopramide (10 mg bolus), a dopamine receptor blocker were studied in 25 consecutive patients with primary hypothyroidism before and after achieving stable euthyroid state and compared with 15 normal age-matched controls. Thyrotropin response to both dopamine infusion (decremental) and IV metoclopramide bolus (incremental) was greater in patients with primary hypothyroidism than that in the control subjects. Thyrotropin response was greater in women than in men. The magnitude of decremental thyrotropin response to dopamine infusion and the incremental response to IV metoclopramide bolus significantly correlated with the basal T₃ and T₄ levels. Thyrotropin response was blunted to dopamine infusion but not to metoclopramide at follow-up after six-month replacement with L-thyroxin, and both the responses were comparable in women and men in patient group. We conclude that modulation of dopaminergic system by dopamine or by dopamine receptor blocker has a greater influence on thyrotropin secretion in patients with primary hypothyroidism than euthyroid normal subjects.

Key words

Dopamine - Metoclopramide - Primary hypothyroidism - Thyrotropin

References

• 1 Jackson I M. Thyrotropin-releasing hormone.  N Engl J Med. 1982;  306 145-155
• 2 Oppenheimer J H, Schwartz H L, Mariash C N, Kinlaw W B, Wong N CW, Freake H C. Advances in understanding of thyroid hormone action at the cellular level.  Endocr Rev. 1987;  8 288-308
• 3 Lamberts S WJ, Zuyderwijk J, den Holder F, Koetsveld P V, Hofland L. Studies on the condition determining the inhibitory effect of somatostatin on adrenocorticotropin, prolactin and thyrotropin release by cultured rat pituitary cells.  Neuroendocrinology. 1989;  50 44-50
• 4 Dieguez C, Foord S M, Peters J R, Hall R, Scanlon M F. Interactions among epinephrine, thyrotropin-releasing hormone, dopamine and somatostatin in the control of TSH secretion in vitro.  Endocrinology. 1984;  114 957-961
• 5 Klibanski A, Milbury P E, Chin W W, Ridgway E C. Direct adrenergic stimulation of the release of thyrotropin and its subunits from the thyrotroph in vitro.  Endocrinology. 1983;  113 1244-1249
• 6 Foord S M, Peters J, Scanlon M F, Rees Smith B, Hall R. Dopaminergic control of TSH secretion in isolated rat pituitary cells.  FEBS Lett. 1980;  121 257-259
• 7 Foord S M, Peters J R, Dieguez C, Shewring G, Hall R, Scanlon M F. Thyrotropin regulates thyrotroph responsiveness to dopamine in vitro.  Endocrinology. 1986;  118 1319-1326
• 8 Chen H J, Meites J. Effects of biogenic amines and TRH on release of prolactin and TSH in the Rat.  J Clin Endocrinol Metab. 1975;  96 10-14
• 9 Feek C M, Sawers J SA, Brown N S, Seth J, Irvine W J, Toft A D. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion.  J Clin Endocrin Metab. 1980;  51 585-589
• 10 Rapoport B, Refetoff S, Fang V S, Friesen H G. Suppression of serum thyrotropin (TSH) by L-Dopa in chronic hypothyroidism.  J Clin Endocrinol Metab. 1973;  36 256-262
• 11 Leblanc H, Lachelin G CL, Abu-Fadil S, Yen S SC. Effect of dopamine infusion on pituitary hormone secretion in humans.  J Clin Endocrinol Metab. 1976;  43 668-674
• 12 Burrow G N, May P B, Spaulding S W, Donabedian R K. TRH and dopamine interactions affecting pituitary hormone secretion.  J Clin Endocrinol Metab. 1977;  45 65-67
• 13 Besses G S, Burrow G N, Spaulding S W, Donabedian R K. Dopamine infusion acutely inhibits the TSH and Prolactin response to TRH.  J Clin Endocrinol Metab. 1975;  41 985-987
• 14 Zulewski H, Muller B, Exer P, Andre R, Staub J J. Estimation of tissue hypothyroidism by a new clinical score: Evaluation of Patients with various grades of Hypothyroidism and controls.  J Clin Endocrinol Metab. 1997;  82 771- 776
• 15 Delitala G. Dopamine and TSH secretion in man.  The Lancet. 1977;  8 760-761
• 16 Cooper D S, Klibanski A, Ridgway E C. Dopaminergic modulation of TSH and its subunits: In vivo and in vitro studies.  Clin Endocrinology. 1974;  16 265-275
• 17 Refetoff S, Fang V S, Rapoport B, Friesen H G. Effect of L-dopa, TSH and thyroid hormone in various combinations.  J Clin Endocrinol Metab. 1983;  38 450-456
• 18 Minozzi M, Faggiano M, Lombardi G. Carella C, Criscuolo T, Scapagnini U. Effect of L-Dopa on plasma TSH levels in primary hypothyroidism.  Neuroendocrinology. 1975;  17 147-153
• 19 Scanlon M F, Weightman D R, Mora B, Heath M, Shale D J, Snow M H, Hall R. Evidence for dopaminergic control of thyrotropin secretion in man.  Lancet. 1977;  27 421-423
• 20 Scanlon M F, Weightman D R, Shale D J, Mora B, Heath M, Snow M H, Lewis M, Hall R. Dopamine is a physiological Regulator of thyrotropin (TSH) secretion in normal man.  Clinical endocrinology. 1979;  10 7-15
• 21 Pourmand N, Rodriguez-Arnao M D, Weightman D R, Hall R, Cook D B, Lewis M, Scanlon M F. Domperidone: A novel agent for the investigation of anterior pituitary function and control in man.  Clinical endocrinology. 1980;  12 211-215
• 22 Faglia G, Beck-Peccoz P, Ferrari C, Ambrosi B, Spada A, Travalini P. Enhanced plasma thyrotropin response to thyrotropin releasing hormone following estradiol administration in man.  Clinical Endocrinology. 1973;  2 207-210
• 23 Lloyd H M, Meares J D, Jacobi J. Early effects of stilboesterol on growth hormone and prolactin secretion and on mitotic activity in the male rat.  J of Endocrinology. 1973;  58 227-231
• 24 Sowers J R, McCallum R W, Harshman J M, Sturdevant R AL, Meyer N. Comparison of metoclopramide with other dynamic tests of prolactin secretion.  J Clin Endocrinol Metab. 1976;  43 679-681
• 25 Feek C M, Sawers J SA, Brown N S, Seth J, Irvine W J, Toft A D. Influence of thyroid status on dopaminergic inhibition of thyrotropin and prolactin secretion.  J Clin Endocrinol Metab. 1980;  51 585-589
• 26 Scanlon M F, Weetman A P, Lewis M, Pourmand M, Rodriguez-Arnao M D, Weightman D R, Hall R. Dopaminergic modulation of circadian thyrotropin rhythms and thyroid hormone levels in euthyroid subjects.  J Clin Endocrinol Metab. 1980;  51 1251-1256
• 27 Scanlon M F, Chan V, Health M, Pourmand M, Rodriguez-Arnao M D, Weightman O R, Lewis M, Hall R. Dopaminergic control of thyrotropin, α-subunit, β-subunits and prolactin in euthyroidism and hypothyroidism.  J Clin Endocrinol Metab. 1981;  58 360-365
• 28 Spitz I M, Treslian S, Cohen H, Arnon N, Roith L D. Failure of metoclopramide to influence LH, FSH and TSH secretion or their responses to releasing hormones.  Acta Endocrinologica. 1979;  92 640-647
• 29 Wayne F L, Louyse A L, Woolf P D. Dopamine affects basal and augmented pituitary Hormone Secretion.  J Clin Endocrinol Metab. 1978;  47 480-487
• 30 Eddy R L, Jones A L, Chakmakjian H, Silverthorne M C. Effect of levadopa (L-DOPA) on human hypophyseal trophic hormone release.  J Clin Endocrinol Metab. 1971;  33 709-712